As we approach the end of Pain Awareness Month, it is important to remember that Porsolt offers a large selection of models …

The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in …

A successful conference so far at the Safety Pharmacology Society annual meeting (SPS 2022) with Sebastien Breche, Kendall Walker PhD., and Sonia …

Porsolt is proud to announce the renewal of its Good Laboratory Practice (GLP) compliance, following a recent external audit by the French …

This one appears in the most recent issue of “International Journal of Molecular Sciences” (Q1 Medicine). The paper highlights the qualities of …

Porsolt is thrilled to have another paper published in oncology: “A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with …

Porsolt, GlioCure, and CHU d’Angers have joined forces in the “Glio Preclinical Solutions (GPS)” collaborative project to develop new and innovative models …

Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how …

A really successful BIO 2022 conference in San Diego last week, consisting of a busy schedule of meetings and concluding with a …

We recently validated two novel reference compounds in our Electrical Amygdala Kindling in vivo model: Retigabine and Perampanel (third generation drug), in keeping …